American Journal of Kidney Diseases
Volume 54, Issue 4 , Pages 653-664 , October 2009

Epithelial-Mesenchymal Transition as a Potential Explanation for Podocyte Depletion in Diabetic Nephropathy

  • Yukinari Yamaguchi, MD

      Affiliations

    • First Department of Internal Medicine, Nara Medical University, Kashihara, Nara, Japan
    • ,
  • Masayuki Iwano, MD

      Affiliations

    • First Department of Internal Medicine, Nara Medical University, Kashihara, Nara, Japan
    • Corresponding Author InformationAddress correspondence to Masayuki Iwano, MD, First Department of Internal Medicine, Nara Medical University, 840 Shijo, Kashihara, Nara 634-8522, Japan
    • ,
  • Daisuke Suzuki, MD

      Affiliations

    • Department of Internal Medicine, Tokai University School of Medicine, Isehara, Kanagawa, Japan
    • ,
  • Kimihiko Nakatani, MD

      Affiliations

    • First Department of Internal Medicine, Nara Medical University, Kashihara, Nara, Japan
    • ,
  • Kuniko Kimura, MD

      Affiliations

    • First Department of Internal Medicine, Nara Medical University, Kashihara, Nara, Japan
    • ,
  • Koji Harada, MD

      Affiliations

    • First Department of Internal Medicine, Nara Medical University, Kashihara, Nara, Japan
    • ,
  • Atsushi Kubo, MD

      Affiliations

    • First Department of Internal Medicine, Nara Medical University, Kashihara, Nara, Japan
    • ,
  • Yasuhiro Akai, MD

      Affiliations

    • First Department of Internal Medicine, Nara Medical University, Kashihara, Nara, Japan
    • ,
  • Masao Toyoda, MD

      Affiliations

    • Department of Internal Medicine, Tokai University School of Medicine, Isehara, Kanagawa, Japan
    • ,
  • Masao Kanauchi, MD

      Affiliations

    • First Department of Internal Medicine, Nara Medical University, Kashihara, Nara, Japan
    • ,
  • Eric G. Neilson, MD

      Affiliations

    • Department of Medicine and Cell and Developmental Biology, Vanderbilt University School of Medicine, Nashville, TN
    • ,
  • Yoshihiko Saito, MD

      Affiliations

    • First Department of Internal Medicine, Nara Medical University, Kashihara, Nara, Japan

Received 16 October 2008 ,Accepted 7 May 2009.

References 

  1. Osterby R, Gall MA, Schmitz A, Nielsen FS, Nyberg G, Parving HH. Glomerular structure and function in proteinuric type 2 (non-insulin-dependent) diabetic patients. Diabetologia. 1993;36:1064–1070
  2. White KE, Bilous RW. Type 2 diabetic patients with nephropathy show structural-functional relationships that are similar to type 1 disease. J Am Soc Nephrol. 2000;11:1667–1673
  3. Lemley KV. Diabetes and chronic kidney disease: Lessons from the Pima Indians. Pediatr Nephrol. 2008;23:1933–1940
  4. Abouna GM, Al-Adnani MS, Kremer GD, Kumar SA, Daddah SK, Kusma G. Reversal of diabetic nephropathy in human cadaveric kidneys after transplantation into non-diabetic recipients. Lancet. 1983;2:1274–1276
  5. Fioretto P, Steffes MW, Sutherland DE, Goetz FC, Mauer M. Reversal of lesions of diabetic nephropathy after pancreas transplantation. N Engl J Med. 1998;339:69–75
  6. Pagtalunan ME, Miller PL, Jumping-Eagle S, et al. Podocyte loss and progressive glomerular injury in type II diabetes. J Clin Invest. 1997;99:342–348
  7. Meyer TW, Bennett PH, Nelson RG. Podocyte number predicts long-term urinary albumin excretion in Pima Indians with type II diabetes and microalbuminuria. Diabetologia. 1999;42:1341–1344
  8. Dalla Vestra M, Masiero A, Roiter AM, Saller A, Crepaldi G, Fioretto P. Is podocyte injury relevant in diabetic nephropathy? (Studies in patients with type 2 diabetes). Diabetes. 2003;52:1031–1035
  9. White KE, Bilous RW. Structural alterations to the podocyte are related to proteinuria in type 2 diabetic patients. Nephrol Dial Transplant. 2004;19:1437–1440
  10. Wolf G, Chen S, Ziyadeh FN. From the periphery of the glomerular capillary wall toward the center of disease: Podocyte injury comes of age in diabetic nephropathy. Diabetes. 2005;54:1626–1634
  11. Lemley KV, Lafayette RA, Safari M, et al. Podocytopenia and disease severity in IgA nephropathy. Kidney Int. 2002;61:1475–1485
  12. Nakamura T, Ushiyama C, Suzuki S, et al. Urinary excretion of podocytes in patients with diabetic nephropathy. Nephrol Dial Transplant. 2000;15:1379–1383
  13. Vogelmann SU, Nelson WJ, Myers BD, Lemely KV. Urinary excretion of viable podocytes in health and renal disease. Am J Physiol Renal Physiol. 2003;285:F40–F48
  14. Chen HC, Chen CA, Guh JY, Chang JM, Shin SJ, Lai YH. Altering expression of alpha3beta1 integrin on podocytes of human and rats with diabetes. Life Sci. 2000;67:2345–2353
  15. Schiffer M, Bitzer M, Roberts IS, et al. Apoptosis in podocytes induced by TGF-beta and Smad7. J Clin Invest. 2001;108:807–816
  16. Ding G, Reddy K, Kapasi AA, et al. Angiotensin II induces apoptosis in rat glomerular epithelial cells. Am J Physiol Renal Physiol. 2002;283:F173–F180
  17. Kumar D, Robertson S, Burns KD. Evidence of apoptosis in human diabetic kidney. Mol Cell Biochem. 2004;259:67–70
  18. Verzola D, Gandolfo MT, Ferrario F, et al. Apoptosis in the kidneys of patients with type II diabetic nephropathy. Kidney Int. 2007;72:1262–1272
  19. Li Y, Kang YS, Dai C, Kiss LP, Wen X, Liu Y. Epithelial-to-mesenchymal transition is a potential pathway leading to podocyte dysfunction and proteinuria. Am J Pathol. 2008;172:299–308
  20. Strutz F, Okada H, Lo CW, et al. Identification and characterization of a fibroblast marker: FSP1. J Cell Biol. 1995;130:393–405
  21. Iwano M, Plieth D, Danoff TM, Xue C, Okada H, Neilson EG. Evidence that fibroblasts derive from epithelium during tissue fibrosis. J Clin Invest. 2002;110:341–350
  22. Barraclough R. Calcium-binding protein S100A4 in health and disease. Biochim Biophys Acta. 1998;1448:190–199
  23. Donato R. S100: A multigenic family of calcium-modulated proteins of the EF-hand type with intracellular and extracellular functional roles. Int J Biochem Cell Biol. 2001;33:637–668
  24. Donato R. Intracellular and extracellular roles of S100 proteins. Microsc Res Tech. 2003;60:540–551
  25. Okada H, Danoff TM, Kalluri R, Neilson EG. Early role of Fsp1 in epithelial-mesenchymal transformation. Am J Physiol Renal Physiol. 1997;273:F563–F574
  26. Okada H, Ban S, Nagao S, Takahashi H, Suzuki H, Neilson EG. Progressive renal fibrosis in murine polycystic kidney disease: An immunohistochemical observation. Kidney Int. 2000;58:587–597
  27. Iwano M, Fischer A, Okada H, et al. Conditional abatement of tissue fibrosis using nucleoside analogs to selectively corrupt DNA replication in transgenic fibroblasts. Mol Ther. 2001;3:149–159
  28. Strutz F, Neilson EG. New insights into mechanisms of fibrosis in immune renal injury. Springer Semin Immunopathol. 2003;24:459–476
  29. Iwano M, Neilson EG. Mechanisms of tubulointerstitial fibrosis. Curr Opin Nephrol Hypertens. 2004;13:279–284
  30. Nishitani Y, Iwano M, Yamaguchi Y, et al. Fibroblast-specific protein 1 is a specific prognostic marker for renal survival in patients with IgAN. Kidney Int. 2005;68:1078–1085
  31. Kalluri R, Neilson EG. Epithelial-mesenchymal transition and its implications for fibrosis. J Clin Invest. 2003;112:1776–1784
  32. Imai E, Horio M, Iseki K, et al. Prevalence of chronic kidney disease (CKD) in the Japanese general population predicted by the MDRD equation modified by a Japanese coefficient. Clin Exp Nephrol. 2007;11:156–163
  33. Cockcroft DW, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron. 1976;16:31–41
  34. Hara M, Yamamoto T, Yanagihara T, et al. Urinary excretion of podocalyxin indicates glomerular epithelial cell injuries in glomerulonephritis. Nephron. 1995;69:397–403
  35. Hara M, Yanagihara T, Takada T, et al. Urinary excretion of podocytes reflects disease activity in children with glomerulonephritis. Am J Nephrol. 1998;18:35–41
  36. Hara M, Yanagihara T, Kihara I. Cumulative excretion of urinary podocytes reflects disease progression in IgA nephropathy and Schönlein-Henoch purpura nephritis. Clin J Am Soc Nephrol. 2007;2:231–238
  37. Suzuki D, Miyazaki M, Naka R, et al. In situ hybridization of interleukin 6 in diabetic nephropathy. Diabetes. 1995;44:1233–1238
  38. Yoshimoto S, Nakatani K, Iwano M, et al. Elevated levels of fractalkine expression and accumulation of CD16+ monocytes in glomeruli of active lupus nephritis. Am J Kidney Dis. 2007;50:47–58
  39. Garrett SC, Varney KM, Weber DJ, Bresnick AR. S100A4, a mediator of metastasis. J Biol Chemi. 2006;281:677–680
  40. Riccioni R, Calzolari A, Biffoni M, et al. Podocalyxin is expressed in normal and leukemic monocytes. Blood Cells Mol Dis. 2006;37:218–225
  41. Skoberne A, Konieczny A, Schiffer M. Glomerular epithelial cells in the urine: What has to be done to make them worthwhile?. Am J Physiol Renal Physiol. 2009;296:230–241
  42. Horvat R, Hovorka A, Dekan G, Poczewski H, Kerjaschki D. Endothelial cell membranes contain podocalyxin—The major sialoprotein of visceral glomerular epithelial cells. J Cell Biol. 1986;102:484–491
  43. Rowe RG, Li XY, Hu Y, et al. Mesenchymal cells reactivate Snail1 expression to drive three-dimensional invasion programs. J Cell Biol. 2009;184:399–408
  44. Iwano M, Kubo A, Nishino T, et al. Quantification of glomerular TGF-beta 1 mRNA in patients with diabetes mellitus. Kidney Int. 1996;49:1120–1126
  45. Yamamoto T, Nakamura T, Noble NA, Ruoslahti E, Border WA. Expression of transforming growth factor beta is elevated in human and experimental diabetic nephropathy. Proc Natl Acad Sci U S A. 1993;90:1814–1818
  46. Kretzler M. Regulation of adhesive interaction between podocytes and glomerular basement membrane. Microsc Res Tech. 2002;57:247–253
  47. Lahdenkari AT, Lounatmaa K, Patrakka J, et al. Podocytes are firmly attached to glomerular basement membrane in kidneys with heavy proteinuria. J Am Soc Nephrol. 2004;15:2611–2618
  48. Bariety J, Nochy D, Mandet C, Jacquot C, Glotz D, Meyrier A. Podocytes undergo phenotypic changes and express macrophagic-associated markers in idiopathic collapsing glomerulopathy. Kidney Int. 1998;53:918–925
  49. Bariety J, Bruneval P, Hill G, Irinopoulou T, Mandet C, Meyrier A. Posttransplantation relapse of FSGS is characterized by glomerular epithelial cell transdifferentiation. J Am Soc Nephrol. 2001;12:261–274
  50. Guo L, Sanders PW, Woods A, Wu C. The distribution and regulation of integrin-linked kinase in normal and diabetic kidneys. Am J Pathol. 2001;159:1735–1742
  51. Han SY, Kang YS, Jee YH, et al. High glucose and angiotensin II increase beta1 integrin and integrin-linked kinase synthesis in cultured mouse podocytes. Cell Tissue Res. 2006;323:321–332
  52. Novak A, Hsu SC, Leung-Hagesteijn C, et al. Cell adhesion and the integrin-linked kinase regulate the LEF-1 and beta-catenin signaling pathways. Proc Natl Acad Sci U S A. 1998;95:4374–4379
  53. Teixeira Vde P, Blattner SM, Li M, et al. Functional consequences of integrin-linked kinase activation in podocyte damage. Kidney Int. 2005;67:514–523
  54. Higgins DF, Kimura K, Bernhardt WM, et al. Hypoxia promotes fibrogenesis in vivo via HIF-1 stimulation of epithelial-to-mesenchymal transition. J Clin Invest. 2007;117:3810–3820

 Originally published online as doi: 10.1053/j.ajkd.2009.05.009 on July 21, 2009.

PII: S0272-6386(09)00832-4

doi: 10.1053/j.ajkd.2009.05.009

American Journal of Kidney Diseases
Volume 54, Issue 4 , Pages 653-664 , October 2009

Article Tools

* Image Usage & Resolution